Market Cap | 3.15B | P/E | 15.61 | EPS this Y | -4.10% | Ern Qtrly Grth | -11.50% |
Income | 193.86M | Forward P/E | 12.40 | EPS next Y | 6.50% | 50D Avg Chg | 9.00% |
Sales | 6.57B | PEG | 1.24 | EPS past 5Y | 10.80% | 200D Avg Chg | 17.00% |
Dividend | 3.00% | Price/Book | 2.85 | EPS next 5Y | 9.00% | 52W High Chg | -1.00% |
Recommedations | 2.70 | Quick Ratio | 0.66 | Shares Outstanding | 89.59M | 52W Low Chg | 39.00% |
Insider Own | 11.37% | ROA | 5.96% | Shares Float | 79.46M | Beta | 1.05 |
Inst Own | 89.39% | ROE | 18.65% | Shares Shorted/Prior | 2.56M/3.04M | Price | 33.10 |
Gross Margin | 21.30% | Profit Margin | 2.95% | Avg. Volume | 816,882 | Target Price | 29.80 |
Oper. Margin | 4.53% | Earnings Date | Jun 19 | Volume | 506,034 | Change | 0.06% |
Patterson Companies, Inc. engages in the distribution of dental and animal health products in the United States, the United Kingdom, and Canada. The company operates through three segments: Dental, Animal Health, and Corporate segments. The Dental segment offers consumable products, including infection control, restorative materials, and instruments; basic and advanced technology and dental equipment; practice optimization solutions, such as practice management software, e-commerce, revenue cycle management, patient engagement solutions, and clinical and patient education systems. It also provides a range of related services comprising software and design services, maintenance and repair, and equipment financing. The Animal Health segment distributes biologicals, pharmaceuticals, vaccines, parasiticides, diagnostics, prescription and non-prescription diets, nutritional's, consumable supplies, equipment, and software, as well as value-added services. This segment also provides private label portfolio of products to veterinarians, producers, and retailers under the Aspen, First Companion, and Patterson Veterinary brands. The Corporate segment offers customer financing services; and sells other miscellaneous products. It serves dentists, laboratories, institutions, other healthcare professionals, veterinarians, other animal health professionals, production animal operators, and animal health product retailers. The company was formerly known as Patterson Dental Company and changed its name to Patterson Companies, Inc. in June 2004. Patterson Companies, Inc. was founded in 1877 and is headquartered in Saint Paul, Minnesota.
Evercore ISI Group | In-Line | Apr 26, 24 |
JP Morgan | Neutral | Mar 6, 24 |
Piper Sandler | Neutral | Feb 29, 24 |
Leerink Partners | Outperform | Feb 26, 24 |
Goldman Sachs | Neutral | Dec 1, 23 |
Piper Sandler | Overweight | Nov 30, 23 |
Morgan Stanley | Equal-Weight | Nov 30, 23 |
Goldman Sachs | Neutral | Nov 30, 23 |
Stifel | Hold | Nov 28, 23 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Zurbay Donald | President & CEO President & CEO | Dec 05 | Sell | 26.58 | 1,868 | 49,651 | 141,923 | 12/07/23 |
BARRY KEVIN MICHAEL | Chief Financial Offi.. Chief Financial Officer | Dec 01 | Sell | 25.36 | 1,627 | 41,261 | 23,103 | 12/04/23 |
ROGAN TIMOTHY E | President - Dental President - Dental | Oct 05 | Sell | 29.7543 | 9,260 | 275,525 | 40,382 | 10/06/23 |
Zurbay Donald | President & CEO President & CEO | Jul 18 | Sell | 32.4828 | 5,620 | 182,553 | 149,539 | 07/19/23 |
KORSH LES B | CLO & Corporate Secr.. CLO & Corporate Secretary | Jul 18 | Sell | 32.4704 | 3,686 | 119,686 | 78,095 | 07/19/23 |
BARRY KEVIN MICHAEL | Chief Financial Offi.. Chief Financial Officer | Dec 05 | Sell | 29.1018 | 9,443 | 274,808 | 6,442 | 12/06/22 |
Zurbay Donald | Chief Financial Offi.. Chief Financial Officer | Jul 06 | Sell | 29.5816 | 10,180 | 301,141 | 78,032 | 07/07/22 |
KORSH LES B | Chief Legal Officer Chief Legal Officer | Jul 06 | Sell | 29.6441 | 4,889 | 144,930 | 71,449 | 07/07/22 |
Frohning Andrea L. | Chief Human Resource.. Chief Human Resources Officer | Jul 06 | Sell | 29.97 | 1,986 | 59,520 | 39,259 | 07/07/22 |
KORSH LES B | Chief Legal Officer Chief Legal Officer | Apr 14 | Sell | 34.9598 | 6,000 | 209,759 | 77,486 | 04/18/22 |
Zurbay Donald | Chief Financial Offi.. Chief Financial Officer | Mar 15 | Sell | 30.8802 | 10,000 | 308,802 | 94,755 | 03/16/22 |
KORSH LES B | VP, General Counsel VP, General Counsel | Mar 15 | Sell | 30.9069 | 6,000 | 185,441 | 83,486 | 03/16/22 |
KORSH LES B | VP, General Counsel VP, General Counsel | Apr 27 | Sell | 33.65 | 1,174 | 39,505 | 101,139 | 04/27/21 |
FERAGEN JODY H | Director Director | Jan 15 | Option | 27.36 | 12,000 | 328,320 | 44,531 | 01/15/21 |
FERAGEN JODY H | Director Director | Jan 15 | Sell | 32.83 | 10,052 | 330,007 | 34,479 | 01/15/21 |